Tsung‐Kun Chang

738 total citations
58 papers, 486 citations indexed

About

Tsung‐Kun Chang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tsung‐Kun Chang has authored 58 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 20 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tsung‐Kun Chang's work include Colorectal Cancer Treatments and Studies (23 papers), Colorectal Cancer Surgical Treatments (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Tsung‐Kun Chang is often cited by papers focused on Colorectal Cancer Treatments and Studies (23 papers), Colorectal Cancer Surgical Treatments (21 papers) and Gastric Cancer Management and Outcomes (16 papers). Tsung‐Kun Chang collaborates with scholars based in Taiwan, China and United States. Tsung‐Kun Chang's co-authors include Jaw‐Yuan Wang, Wei‐Chih Su, Hsiang‐Lin Tsai, Ching‐Wen Huang, Yen‐Cheng Chen, Yung‐Sung Yeh, Po-Jung Chen, Cheng‐Jen Ma, Hsiang‐Lin Tsai and Chun‐Ming Huang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tsung‐Kun Chang

55 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsung‐Kun Chang Taiwan	13	266	141	138	111	84	58	486
Hsiang‐Lin Tsai Taiwan	15	286 1.1×	220 1.6×	130 0.9×	108 1.0×	204 2.4×	46	555
Hsiang-Lin Tsai Taiwan	11	210 0.8×	94 0.7×	122 0.9×	95 0.9×	68 0.8×	23	464
Søren Astrup Jensen Denmark	13	393 1.5×	93 0.7×	62 0.4×	109 1.0×	65 0.8×	21	654
Denise Kalmaz United States	10	219 0.8×	164 1.2×	179 1.3×	204 1.8×	29 0.3×	21	621
Akihiko Koike Japan	13	254 1.0×	133 0.9×	140 1.0×	89 0.8×	69 0.8×	39	556
Sea Hyub Kae South Korea	18	139 0.5×	152 1.1×	434 3.1×	269 2.4×	89 1.1×	49	729
Chaojie Huang China	13	198 0.7×	152 1.1×	190 1.4×	192 1.7×	98 1.2×	26	484
Erjiang Zhao China	12	94 0.4×	158 1.1×	85 0.6×	72 0.6×	53 0.6×	22	351
Eri Munekage Japan	12	136 0.5×	37 0.3×	131 0.9×	159 1.4×	35 0.4×	36	376

Countries citing papers authored by Tsung‐Kun Chang

Since Specialization

Citations

This map shows the geographic impact of Tsung‐Kun Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung‐Kun Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung‐Kun Chang more than expected).

Fields of papers citing papers by Tsung‐Kun Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung‐Kun Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung‐Kun Chang. The network helps show where Tsung‐Kun Chang may publish in the future.

Co-authorship network of co-authors of Tsung‐Kun Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung‐Kun Chang. A scholar is included among the top collaborators of Tsung‐Kun Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung‐Kun Chang. Tsung‐Kun Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chuang, Jen‐Pin, Po‐Jung Chen, Wei‐Chih Su, et al.. (2025). Smoking and Elevated Preneoadjuvant Chemoradiotherapy Serum Carcinoembryonic Antigen Levels Are Associated With High Tumor Regression Grade and Poor Survival in Patients With Locally Advanced Rectal Cancer. The Kaohsiung Journal of Medical Sciences. 41(6). e70008–e70008.

2.

Chang, Yu‐Tang, Hsiang‐Lin Tsai, Yen‐Cheng Chen, et al.. (2023). Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy. Journal of Oncology. 2023. 1–9. 3 indexed citations

3.

Chen, Yen‐Cheng, Ching‐Wen Huang, Tsung‐Kun Chang, et al.. (2023). Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis. World Journal of Surgical Oncology. 21(1). 378–378. 4 indexed citations

4.

Chen, Po-Jung, Yung‐Sung Yeh, Yen‐Cheng Chen, et al.. (2023). Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy. Frontiers in Oncology. 13. 1099168–1099168. 2 indexed citations

5.

Huang, Chun‐Ming, Hsiang‐Lin Tsai, Yen‐Cheng Chen, et al.. (2022). Role of non-coding RNAs in radiosensitivity of colorectal cancer: A narrative review. Frontiers in Oncology. 12. 889658–889658. 7 indexed citations

6.

Shi, Hon‐Yi, Yen‐Cheng Chen, Ching‐Wen Huang, et al.. (2022). Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study. Frontiers in Oncology. 12. 756078–756078. 2 indexed citations

7.

Su, Wei‐Chih, Fang‐Ming Chen, Hsiang‐Lin Tsai, et al.. (2020). Effects of Good Pain Management (GPM) ward program on patterns of care and pain control in patients with cancer pain in Taiwan. Supportive Care in Cancer. 29(4). 1903–1911. 4 indexed citations

8.

Su, Wei‐Chih, Tsung‐Kun Chang, Cheng‐Jen Ma, et al.. (2020). Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study. World Journal of Surgical Oncology. 18(1). 308–308. 8 indexed citations

9.

Chang, Tsung‐Kun, Ching‐Wen Huang, Wei‐Chih Su, et al.. (2020). Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial. SHILAP Revista de lepidopterología. 9(2). 671–681. 11 indexed citations

10.

Ma, Cheng‐Jen, Ching‐Wen Huang, Yung‐Sung Yeh, et al.. (2020). Supplemental home parenteral nutrition improved nutrition status with comparable quality of life in malnourished unresectable/metastatic gastric cancer receiving salvage chemotherapy. Supportive Care in Cancer. 29(4). 1977–1988. 11 indexed citations

11.

Tsai, Hsiang‐Lin, Ching‐Wen Huang, Cheng‐Jen Ma, et al.. (2019). An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness. Translational Cancer Research. 8(6). 2357–2370. 2 indexed citations

12.

Tsai, Hsiang‐Lin, Tsung‐Kun Chang, Wei‐Chih Su, et al.. (2019). Comparing efficacy and safety between Naldebain® and intravenous patient-controlled analgesia with fentanyl for pain management post-laparotomy: study protocol for a randomized controlled, non-inferior trial. Trials. 20(1). 173–173. 1 indexed citations

13.

Wang, Jaw‐Yuan, et al.. (2019). Ectopic pancreas mimicking gastric submucosal tumour treated using robotic surgery. Journal of Minimal Access Surgery. 16(2). 179–179. 2 indexed citations

14.

Tsai, Hsiang‐Lin, Ching‐Wen Huang, Cheng‐Jen Ma, et al.. (2019). An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness. Translational Cancer Research. 8(6). 2357–2370. 5 indexed citations

15.

Ma, Cheng‐Jen, Tsung‐Kun Chang, Hsiang‐Lin Tsai, et al.. (2019). Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients:study protocol for a randomized controlled trial. Trials. 20(1). 751–751. 6 indexed citations

16.

Tsai, Hsiang‐Lin, Yung‐Sung Yeh, Cheng‐Jen Ma, et al.. (2019). Impact of a Dual-Ring Wound Protector on Outcome After Elective Surgery for Colorectal Cancer. Journal of Surgical Research. 244. 136–145. 6 indexed citations

17.

Su, Wei‐Chih, Hsiang‐Lin Tsai, Yung‐Sung Yeh, et al.. (2018). Combined computed tomography-measured tumor density and RECIST for evaluating neoadjuvant therapy in locally advanced gastrointestinal stromal tumors. Translational Cancer Research. 7(3). 634–644. 1 indexed citations

18.

Chen, Brian Po‐Jung, Ching‐Wen Huang, Hsiang‐Lin Tsai, et al.. (2018). Robotic-assisted total mesorectal excision in low-lying rectal cancer. Mini-invasive Surgery. 2018. 1 indexed citations

19.

Chang, Tsung‐Kun, Hsiang‐Lin Tsai, Wei‐Chih Su, et al.. (2018). The clincopathological variables to differentiate the nature of isolated pulmonary nodules in patients who received curative surgery for colorectal cancer. Asian Journal of Surgery. 42(2). 425–432. 5 indexed citations

20.

Wong, Tai‐Tong, et al.. (1997). Neuropsychological sequelae after treatment for medulloblastoma in childhood - the Taiwan experience. Child s Nervous System. 13(2). 77–80. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact